New hope for kids with tough cancers: testing a promising drug
Disease control
Recruiting now
This study is testing a drug called ponatinib in children and teenagers (ages 1 to 18) whose cancers have come back or have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help control various advanced cancers, including leukem…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences International Sàrl • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC